维普期刊资源整合服务平台（V6.5）

21篇 您的检索式：作者名="Giotta F"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	Carboplatin in combi- nation with raltitrexed in recurrent and metastatic head and neck squamous cellcarcinoma 显示文摘	Galetta D Giotta F Rosati G	2005	Anticancer Res2005，25，7：	1
2	Heavy metal ion influence on the photosynthetic growth of Rhodobactersphaeroides 显示文摘	Giotta L Agostiano A haliano F	2006	Chemosphere2006，62，9：	1
3	Efficacy and safety of zoledronic acid in patients with breast cancer metastatic to bone: a muhicenter clinical trial显示文摘	Carteni G Bordonaro R Giotta F	2006	Oncologist2006，11，7：	1
4	A Multieenter Phase Ⅱ random- ized trial ofdocetaxel/gemcitabine versus docetaxel/capecitabine as first - line treatment for advanced breast cancer : A Gruppe Oncolog- ico Italia Meridionale Study 显示文摘	Vici P Giotta F Di Laura L	2011	Oncology2011，81，34：	1
5	Efficacy and Safety of Zole-dronic Acid in Patients with Breast Cancer Metastatic to Bone:A Mul-ticenter Clinical显示文摘	Carteni G Bordonaro R Giotta F	2006	The oncologist2006，11，：	1
6	Efficacy and safety of zoledronic acid inpatients with breast cancer metastatic to bone:a multicenter clinical trial显示文摘	Carteni G Bordonaro R Giotta F		0，，：	1
7	Quality of life,fatigue and depression in Italian long-term breast cancer survivors显示文摘	Romito F Cormio C Giotta F	2012	Support Care Cancer2012，20，11：	1
8	A multicenter phase II randomized trial of docetaxel/gemcitabine versus docetaxel/ capecitabine as first-line treatment for advanced breast canc- er~a gruppo oncologieo Italia meridionale study显示文摘	Vici P Giotta F Di Lauro L	2011	Oncolo- gy2011，81，34：	1
9	A muhicenter phase II randomized trial of docetaxel/gemcitabine versus docetaxel/capecitabine as first-linetreatment for advanced breast cancer: A gruppo oncologico italia merid- ionale study显示文摘	Vici P Giotta F Di Lauro L	2011	Oncology2011，81，34：	1
10	Gemcitabine and docetaxel every 2 weeks in advanced non-small cell lung cancer:a phase Ⅱ study of the gruppo oncologico italia meridionale显示文摘	Galetta D Gebbia V Giotta F	2002	Lung Cancer2002，38，1：	1
11	A muhicenter phase II ran- domized trial of docetaxel/gemcitabine versus docetaxel/capecit- abine as first-line treatment for advanced breast cancer: a Gruppo Oncologico Italia Meridionale study显示文摘	Vici P Giotta F Di Lauro L	2011	Oncology2011，81，34：	1
12	Efficacy and safety of zoledronic acid in patients with breast cancer metastatic to bone: a multicenter clinical trial显示文摘	Cartcni G Bordonaro R Giotta F	2007	Oncologist2007，，11：	1
13	A multicenter phase II randomized trial of doeetaxel/gemcitabine versus docetaxel/ capecitabine as first-line treatment for advanced breast cancer: A gruppo oncologico italia meridionale study 显示文摘	VICI P GIOTTA F DI LAURO L	2011	Ontology2011，81，34：	1
14	A Multicenter Phase Ⅱ ran- domized trial of docetaxel/gemcitabine versus docetaxel/ eapecitabine as first- line treatment for advanced breast cancer: A Gruppo Oncologico Italia Meridionale Study显示文摘	Vici P Giotta F Di Lauro L	2011	Oncology2011，81，34：	1
15	Endiocrine and metabolic effects of octreotide, a so matostatin analogue, in lean PCOS patients with either hyperinsulinaemia or lean nor moininsulinaemia显示文摘	GIOTTA L DELEO V GALVANI F	1999	Hum Reprod1999，14，12：	1
16	Efficacy and safety of zoledronic acid in patients with breast cancer metastatic to bone:a multicenter clinical trial显示文摘	Carteni G Bordonaro R Giotta F	2006	Oncologist2006，11，7：	1
17	Efficacy and safety of zoledronic acid in patients with breast cancer metastatic to bone: a multicenter clinical trial显示文摘	Cartenl G Bordonaro R Giotta F	2006	Oncologist2006，11，7：	1
18	Efficacy and safety of zoledronic acid in patients with breast cancer metastatic to bone:a multicenter clinical trial显示文摘	Carteni G Bordonaro R Giotta F	2006	Oncologist2006，11，7：	1
19	A Multicenter Phase Ⅱ randomized trial of docetaxel/gemcitabine versus docetaxel/capecitabine as first-line treatment for advanced breast cancer:A Gruppo Oncologico Italia Meridionale Study显示文摘	Vici P Giotta F Di Lauro L	2011	Oncology2011，81，34：	1
20	A multicenter phase Ⅱ randomized trial of docetaxcl/gemcitahine versus docetaxellcapecitahine as first- line treatment for advanced breast caneer:a Gruppo Oncologico Italia Meridionale Study显示文摘	Vici P Giotta F Di Lauro L ct al	2011	Ontology2011，81，34：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示